Katherine M. Moxley, M.D., named director of gynecologic oncology

September 22, 2021  //  FOUND IN: Strategy & Leadership

Katherine M. Moxley, M.D., has been named director for the Division of Gynecologic Oncology in the Department of Obstetrics and Gynecology.

Moxley comes from the University of Oklahoma, where she served as the Mai Eager Anderson Chair in Cancer Clinical Trials.

Despite being born in Michigan, Moxley has spent her entire career to date at the University of Oklahoma, where she completed medical school, OB-GYN residency and her gynecologic oncology fellowship. She joined the faculty in 2011 and was promoted to associate professor in 2018.

In addition to being an exceptional clinician, surgeon and educator, Moxley brings a wealth of experience and success in leading clinical trials as well as being a basic science investigator. She is the principal investigator or co-investigator on seven grants, including funding from the National Cancer Institute. Her research to date has helped to navigate molecular mechanism of drug resistance, exosome-mediated tumor signaling specifically the role of exosomal contents on the tumor microenvironment and in facilitating immune anergy and drug resistance.

Nationally, Moxley is a member of the Society of Gynecologic Oncology’s Wellness Task Force, an NRG representative of the Cervical Task Force of the National Cancer Institute Gynecologic Steering Committee, and co-chair of the Gynecologic Oncology Group/NRG and GOG-Partners Cervical Cancer Publications Committee.